close
Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.
Germany’s BioNTech SE signed a preliminary deal to set up a facility to produce cancer-related drugs and vaccines in Jerusalem, Israel’s Finance Ministry said on Tuesday.
MISSING PORCUPINE THAT DISAPPEARED FROM GERMAN ZOO FINDS ITS WAY BACK HOME
The logo of BioNTech is seen in Marburg, Germany, on Feb. 2, 2023. (REUTERS/Fabian Bimmer)
CLICK HERE TO GET THE FOX NEWS APP
Under the memorandum of understanding, BioNTech will develop the drugs and vaccines using mRNA technology in the Har Hotzvim technology park. It will also set up a research centre at the Weizmann Institute in central Israel.
Amazon has agreed to pay $2.5 billion to settle allegations brought by the Federal Trade…
Sportswear and fitness brand Under Armour is investigating claims of a massive data breach after…
IN TODAY’S NEWSLETTER: - Amazon to cut 16,000 roles as it looks to invest in…
YouTube is rolling out new parental controls designed to give families more say over how…
What happens when artificial intelligence (AI) moves from painting portraits to designing homes? That question…
Apple often promotes the App Store as a secure place to download apps. The company…